US equities |
GOOGL $324.89 ▲+0.00% GOOG $321.89 ▲+0.00% MU $983.23 ▲+0.00% SNDK $1,404.77 ▲+0.00% SKHY $164.70 ▲+0.00% LITE $913.95 ▲+0.00% MSFT $531.01 ▲+0.00% INTC $95.53 ▲+0.00%
FinancialContent

Alpha Cognition Inc (OP:ACOGF)

0.3500 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alpha Cognition Inc

< Previous 1 2 Next >
News headline image
Alpha Cognition Announces Grant of Stock Options
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces First Quarter 2022 Results and Company Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Fourth Quarter and Full Year 2021 Results and Company Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Change of CFO, Grant of Stock Options and Addition to the Board of Directors
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Positive Data from Pre-Clinical Studies of ALPHA-0602 (Progranulin) for Amyotrophic Lateral Sclerosis (ALS)
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Positive Neuroprotection Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Participation in January Investor Conferences
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Director Change and Stock Option Grant
From Alpha Cognition Inc.
Via Business Wire
News headline image
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday ↗
Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
News headline image
Alpha Cognition Announce Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Appoints Cedric O’Gorman, M.D., MBA as Chief Medical Officer
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Reports Third Quarter of Fiscal 2021 Results
From Alpha Cognition Inc.
Via Business Wire
News headline image
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will... 
From Stock News Now
Via AccessWire
Alpha Cognition Inc. (TSX.V: ACOG) (OTCQB: ACOGF) Featured in Coverage of Investor Summit Group’s Q4 Virtual Event
Via Investor Brand Network
News headline image
Alpha Cognition to Present at LD Micro Main Event
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Provides CEO Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Formation and Members of Scientific Advisory Board and Investor Relations Agreements
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Attracts New Investors as Future Leader in Growing Alzheimer's Disease Market ↗
Image Provided By Unsplash The premier marketplace for early stage and developing companies approved the clinical stage biopharmaceutical company, Alpha Cognition Inc. (OTCQB:... 
Via Benzinga
News headline image
Alpha Cognition, Focused on Neurodegenerative Diseases, CEO Clip Video
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2021) - Alpha Cognition (TSXV: ACOG) (OTCQB: ACOGF) - CEO, Michael McFadden speaks... 
Via Newsfile
News headline image
Alpha Cognition Announces the Acceptance of its US FDA Investigational New Drug Application (IND) for Lead Candidate, ALPHA-1062 for Mild to Moderate Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Reports Second Quarter of Fiscal 2021 Results
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Receives Approval to Commence Trading on the OTCQB
From Alpha Cognition Inc.
Via Business Wire
< Previous 1 2 Next >